Author: Capucine Lepicard

📱 EviRed : They talk about us ! 📱

Posted on | by Capucine Lepicard

We are thrilled to announce that EviRed’s new videos are now available! đŸŽ„

  • Want to learn more about EviRed programm?

The « JT de l’ophtalmologie » interview from EviRed’s team members , provides information about the mission, goals, challenges and next steps for EviRed . Listen  to Pr Aude Couturier, Capucine Lepicard, Dr Sophie Bonnin, and Gwenole Quellec tell you more.

  • Want to learn about EvIred cohort included ?.

Don’t miss the  interview ( in French)  with Pr Pascale Massin, who provides insights into the EviRed cohort design and description. presents the first trends observed in the cohort.

Click :Here

 

Stay tuned for more updates !

EviRed highlights in the ARVO and SFO 2025, main conferences for Ophthalmology and Research

Posted on | by Capucine Lepicard

The French ophthalmology community had 2 importants events in the last 2 weeks :

  • First of all, some members of EviRed team attended the Association for Research in Vision and Ophthalmology (ARVO) 2025 conference, held in Salt Lake City, Utah, from May 4th to 8th. This conference brings annually together the ophthalmology research community.

Mostafa El Habib Daho presented a very interesting poster entitled « Device-Agnostic Deep Learning Framework for Diabetic Retinopathy Grading Using Ultra-Widefield Fundus Photography ».

And Carla Danese presented a poster related to « the effect of a new antidiabetic drugs on one-year change of OCT-A metrics, work performed on EviRed data ».

 

  • Then, some EviRed team members  attended the SFO 2025 (annual meeting of the French Ophthalmology Society) in Paris from May 10th to 12th.

EviRed was highlighted, as examples,

  • During a passionated 2h session organized by SFO titled « IA from today to tomorrow in ophthalmology » where the Evired Partners were well represented by Prof. Beatrice Cochener from the LaTIM, Prof. Aude Couturier from AP-HP and StĂ©phanie Magazzeni from ZEISS as key speakers.
  • During a retina-dedicated session, Prof. Pascale Massin presented a description of the population included in EviRed cohort.

Those meetings are always a good moment to exchange and meet with our partners.

On the pictures :

  • On the top, during ARVO 2025 (from left to right and from the top to the bottom)
    • C. Danese
    • D. Cosette, M. Lamard, A. Couturier, M. El Habib Daho, S. Gate, I. Raden, S. Magazzeni, A. Saheli
    • S. Bonnin, D. Cosette, M. El Hadi Daho
    • M. Lamard, A.Couturier , M. El Habib Daho , S. Bonnin, F. Potevin et J. Abou Assi
  • During the SFO 2025
    • From the top to bottom, and from left to right : L. Foulon-Pinto, S. Bonnin, Q. Bougault, M. Hemmendinger ,P. Massin, A. Couturier, C. Lepicard, T Hamlat, R. Ben Othman
    • On the right, P Massin during the retina-dedicated session
    • On the left, B. Cochener during the AI conference

                                            

Deep Learning tools for evaluation of diabetic retinopathy and maculopathy »PhD thesis defended by Dr. H. Le Boite

Posted on | by Capucine Lepicard

On April 8th, 2025, Dr. Hugo Le BoitĂ© successfully defended his PhD thesis titled “Deep Learning tools for evaluation of diabetic retinopathy and maculopathy”. This marked the culmination of a three and a half-year journey during which Dr. Le BoitĂ© developed and applied tools for the segmentation of retinal non-perfusion in OCT-Angiography images in diabetic retinopathy, tools for the segmentation of pathological fluids in OCT images, as well as innovative methodological approaches to alleviate the manual annotation burden when constructing large database of medical images in the purpose of training efficient deep learning models.

The defense was held in the presence of a jury comprising the following members:

  • Mr. Raphael Sznitman: professor and research director at the ARTORG center for biomedical engineering and research, Bern Switzerland.
  • Ms. Alexandre Miere: assistant professor of ophthalmology in the ophthalmology department of the Creteil Hospital (Centre Hospitalier Intercommunal de CrĂ©teil, France)
  • Mr. Fabrice Meriaudeau: professor, and research director at the Medical Imaging group, UniversitĂ© de Bourgogne. President.
  • Mr. Xavier Guillonneau: research director at the Institut de la Vision, Sorbonne UniversitĂ©, Paris, France.
  • Ms. Catherine Creuzot Garcher: professor, ophthalmology department of the Dijon University Hospital, France.
  • Mr. GwenolĂ© Quellec: research director, INSERM, LaTIM, UMR-1101.
  • Ms. Aude Couturier: professor, ophthalmology department of the LariboisiĂšre hospital, Paris, France.

This research provides potential deep learning tools that could be applied in clinical practice for automatic segmentation of specific biomarkers, but also provides interesting methodological techniques that will be applied in future projects in order to optimize manual annotation in the production of medical image segmentations.

Appearing in the top picture, from left to right: Fabrice Meriaudeau, Hugo Le Boité, Xavier Guillonneau, Gwenolé Quellec, Aude Couturier, Alexandra Miere. Catherine Creuzot Garcher and Raphael Sznitman participated remotely.

The Evired Team at « Retine en Pratique » in Paris on the 28th March 2025

Posted on | by Capucine Lepicard

Part of the Evired Team met during the 20th edition of the « Rétine en Pratique » congress organized in Paris on the 28th of March and led by Pr Aude Couturier and Pr Alain Gaudric.

The congress was dedicated to all secrets of the choroid and we learned a lot!

It is always a pleasure to exchange all together on Retina topic.

Members of the clinical sites (principal investigators, investigators, orthoptists, study coordinators
) and reading center graders were present.

Although the congress had over 500 participants, only a small number of us were available to be present for the photo.

The EviRed adventure continues, so stay tuned!

Celebrate the 5th anniversary of EviRed! 🎉

Posted on | by Capucine Lepicard

Today, we are delighted to celebrate an important milestone in our journey: the fifth anniversary of our project!

Over the past five years, we have had the honor to work on this innovative project promoted by AP-HP and supported by ANR and we would like to share our achievements and their impact :

  • More than 3000 patients are enrolled in the clinical study in the 14 French sites. Their longitudinal data collected (contextual data and images) are key for the project. Deep Thanks to the patients for their contribution
 And we are happy to announce that the follow up will continue this year !

We want to express our gratitude to all the stakeholders at sites for the tremendous work they accomplish daily: investigators, co-investigators, orthoptistes and study coordinators that follow the daily work on site.

A big shout also to the URC team improving the   data set quality with their data cleaning activities.

  • Our industrial partners Evolucare, Adcis and ZEISS worked hand-in -hands with AP-HP to enable the review of all the patient collected images  at the reading center based in LariboisiĂšre hospital AP-HP.

Thanks to IT Teams and partners to permit the set of the reading center and to the graders and supergraders. The reading center already reviewed more than 15 000 images!

  • Our dedicated Ai teams have already published several articles on various innovative approachs for the developement of algorithms wich could ultimately  serve unmet needs in Diabetic Retinopathy.Thanks to LaTim teams.

 

This year is particularly special, as it marks the last step before finalizing our algorithm. We look forward to sharing with you the advances that will transform the life of patients and impact the daily lives of ophthalmologists to choose the best strategy on the monitoring of the Diabetic Retinopathy

Thank you to all who have been with us throughout this journey. Your support is invaluable and we look forward to continuing this adventure together!

🎈 Let’s stay connected and celebrate together! 🎈

Longitudinal and Multi-Modal Monitoring for Diabetic Retinopathy Detection Using Deep Learning” thesis Defense by Rachid Zeghlache

Posted on | by Capucine Lepicard

On December 12, 2024, Dr. Rachid Zeghlache successfully defended his PhD thesis titled “Longitudinal and Multi-Modal Monitoring for Diabetic Retinopathy Detection Using Deep Learning”. This marked the culmination of a three-year journey during which Dr. Zeghlache explored various innovative approaches to tackle a central challenge of the Evired project: predicting the future progression of diabetic retinopathy in patients based on imaging and contextual data.

The defense was held in the presence of a jury comprising the following members:

  • Mr. François ROUSSEAU: Professor, IMT Atlantique, president
  • Ms. Alice OTHMANI: Associate Professor (HDR), LISSI, UniversitĂ© Paris-Est CrĂ©teil (UPEC), reviewer
  • Ms. Marie BEURTON-AIMAR: Associate Professor (HDR), LaBRI, UniversitĂ© Bordeaux, reviewer
  • Mr. GwenolĂ© Quellec: Research Director, INSERM, LaTIM, UMR-1101
  • Mr. Mathieu LAMARD: Research Engineer (HDR), LaTIM, UMR-1101, director
  • Mr. Pierre-Henri CONZE: Associate Professor (HDR), IMT Atlantique
  • Mr. Mostafa EL HABIB DAHO: Researcher (CPJ), UBO – HDR, LaTIM, UMR-1101

This groundbreaking research lays the foundation for personalized, AI-driven management of diabetic retinopathy and is expected to inspire significant innovations during the final stages of the Evired project.

NB: on the picture from the left to the right: François Rousseau, Pierre-Henri Conze, Gwenolé Quellec, Dr. Rachid Zeghlache, Mathieu Lamard, Alice Othmani, Mostafa El Habib Daho (Marie Beurton-Aimar participated remotely).